Are you an early career researcher (ECR) in cancer research? Apply to our #ECR Workshop and learn how to navigate some of the common challenges experienced by ECRs. Application deadline: September 30, 2024 Learn more: bit.ly/42dmy3e

Conflicts on interest in healthcare continue to adversely impact what we do. The coverage of lecanemab and NICE decision - look for undisclosed interests…. | Margaret McCartney | The Guardian theguardian.com/commentisfree/…

How do people catch up on emails post vacation? I feel swamped! Maybe I need to put 2 more days into the vacation schedule just to catch up on emails? 🤷‍♂️

So based on the majority opinion, I’m ignoring all those emails. So if I haven’t answered you, please email me again. 😃

Don’t forget to register!

In this insightful comment on Nature Reviews Cancer Carolyn Taylor shared: “I discovered that 70–80% of patients in LMICs are diagnosed at a late stage and typically die within 2 years of receiving their diagnosis” nature.com/articles/s4157… #ChokeCancer

A must-read patient/survivor/advocate perspective shedding light on the need to redefine priorities in cancer care and research. nature.com/articles/s4157… NatureRevClinOncol

One of my favourite authors of modern times. Chuck Palahniuk

Don’t underestimate the benefits of a good nap. Time spent napping is never time wasted.

Despite multiple guidelines, including ‘Choosing Wisely’, advocating against the use of PET-CT for surveillance of patients with cancer treated with curative intent, we see widespread PET-CT imaging. bmjoncology.bmj.com/content/3/1/e0…

Despite editing a manuscript so many times during Draft 1, Draft 2, Draft 100, Final draft 1, Final draft 50, Final final draft, really final draft, revision 1, revision 2, revision 5, …. And getting it accepted, You still find dozens of things to revise during proofreads! 🤷‍♂️

Oncology is a multi billion dollar market. Unsurprisingly and unfortunately, therefore economics dictate the practice of oncology more than science and evidence. fiercehealthcare.com/providers/mcke… HT Kevin Knopf

See you at #ESMO2024 at the Common Sense Oncology symposium! Join us on 09/13/24 at Vall d'Hebron to discuss #CommonSenseOncology in European Oncology. Great speakers @BishalGyawali @DarioTrapani @Lastra_Rod Bishal Gyawali. 🚍🍴included. Register here: …independientedeoncologia.blogspot.com/2024/09/common…

If you're @Barcelona on Sept 13th 🇪🇸, join the discussion at Vall d’Hebron Institute of Oncology (VHIO) with the Common Sense Oncology ! 👨🏻‍💼 Meet Joan Brunet Institut Català d'Oncologia & the Spanish oncologists driving oncology to a next step! Rodrigo Lastra del Prado Javier David Benitez Fuentes #RIO …independientedeoncologia.blogspot.com/2024/09/common…

I'm not missing this one!

COMMON SENSE ONCOLOGY #ESMO24 Speakers: Joan Brunet Bishal Gyawali WinetteVanDerGraaf Dario Trapani and my self Registration free!!. Link for RSVP: us14.list-manage.com/survey?u=b282f… Program and details: …independientedeoncologia.blogspot.com/2024/09/common…

Reminder to #ECRs! The application deadline for our ECR Workshop is September 30, 2024. Join fellow ECRs for a full day of learning, networking and skill development in cancer research! Learn more: bit.ly/42dmy3e

Don't forget to join us at #ESMO24 next Friday 2pm for an exciting session on ESMO-MCBS. ESMO - Eur. Oncology

On this day 5 years ago! We have come a long way in advocating for common sense in oncology. Common Sense Oncology

Trial Authors: Details are described in the Protocol available in the Supplementary Appendix. Supplementary Appendix: Read me if you can!